- cafead   Jan 08, 2019 at 09:22: AM
via Sanofi "flipped the model" with its Dengvaxia launch and initially focused on emerging countries, but that created unforeseen challenges, the French drugmaker's vaccines chief said. Overly rosy sales projections didn't help, either.
article source
article source